Journal Report

Journal of infectious diseases (The)

Download PDF
Journal Information
Journal Title
Journal of infectious diseases (The)
Publisher
ISSN
0022-1899
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Circulating Zika and dengue IgA-NS1 marks early postnatal exposure without significant association with congenital Zika syndrome-related microcephaly
Juanita Castro-Meneses, Sebastián Castro-Trujillo, William R Mejía et al.
2026-10-31
Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016–17 Through 2024–25
Jessica R Meeker, Ashley M Price, Emily Martin et al.
2026-10-31
Predictors of Incident Hepatic Fibrosis and Steatotic Liver Disease–Associated Fibrosis Among Women with and without HIV
Maria J Duarte, Phyllis C Tien, Yifei Ma et al.
2026-10-31
Toward a Brighter Future in Vaccine Safety Science: A Call For Investments, Capitalizing on Scientific Opportunities and A National Vaccine Safety Board
Daniel A Salmon, Jim Buttery, Bruce Carleton et al.
2026-10-30
A Live Attenuated Dengue Virus Vaccine (Dengvaxia) is Suppressed in Individuals with Immunity to Serotype 4
Cameron Adams, Lindsay D Hein, Laura J White et al.
2026-10-28
Potential Synergistic Association of Donepezil and Metformin With COVID-19 Mortality in Dementia Patients
Bingnan Li, Andreas Handel, Ye Shen et al.
2026-10-28
Obesity in Children is Associated With Increased Dengue Virus Binding, but not Neutralizing, Antibody Responses Following Primary Infection
Reinaldo Mercado-Hernandez, Sandra Bos, Angel Balmaseda et al.
2026-10-28
Cryptosporidiosis at a Crossroads
Audrey R Odom John
2026-10-28
Transplantation and the HIV Latent Viral Reservoir
J Natalie Howard, Melissa L Smith, Ashwin Balagopal et al.
2026-10-28
IL-6 Blockade With Clazakizumab Is Associated With Low Myeloid Cell Activation and Increased Type 2 Immune Responses in Nonsurvivors of COVID-19
Laila Stoddart, Trevor S Johnston, Weiqiang Zhou et al.
2026-10-27
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 19:12